Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Emerging insights into resistance to BRAF inhibitors in melanoma.
Biochem Pharmacol. 2014 Feb 1;87(3):381-9. doi: 10.1016/j.bcp.2013.11.013. Epub 2013 Nov 28.
Biochem Pharmacol. 2014.
PMID: 24291778
Review.
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
Bucheit AD, Syklawer E, Jakob JA, Bassett RL Jr, Curry JL, Gershenwald JE, Kim KB, Hwu P, Lazar AJ, Davies MA.
Bucheit AD, et al.
Cancer. 2013 Nov 1;119(21):3821-9. doi: 10.1002/cncr.28306. Epub 2013 Aug 6.
Cancer. 2013.
PMID: 23922205
Free article.
Item in Clipboard
Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
Bucheit AD, Chen G, Siroy A, Tetzlaff M, Broaddus R, Milton D, Fox P, Bassett R, Hwu P, Gershenwald JE, Lazar AJ, Davies MA.
Bucheit AD, et al.
Clin Cancer Res. 2014 Nov 1;20(21):5527-36. doi: 10.1158/1078-0432.CCR-14-1027. Epub 2014 Aug 27.
Clin Cancer Res. 2014.
PMID: 25165098
Free PMC article.
Item in Clipboard
Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy.
Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, Brown PD, Davies MA, Sulman EP.
Fang P, et al. Among authors: bucheit ad.
J Neurooncol. 2018 Mar;137(1):67-75. doi: 10.1007/s11060-017-2695-2. Epub 2017 Dec 2.
J Neurooncol. 2018.
PMID: 29198052
Item in Clipboard
Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition.
Bucheit AD, Hardy JT, Szender JB, Glitza Oliva IC.
Bucheit AD, et al.
Melanoma Res. 2020 Aug;30(4):423-425. doi: 10.1097/CMR.0000000000000657.
Melanoma Res. 2020.
PMID: 32073510
Item in Clipboard
ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
Lorenzatti Hiles G, Bucheit A, Rubin JR, Hayward A, Cates AL, Day KC, El-Sawy L, Kunju LP, Daignault S, Lee CT, Liebert M, Hussain M, Day ML.
Lorenzatti Hiles G, et al.
PLoS One. 2016 Mar 1;11(3):e0150138. doi: 10.1371/journal.pone.0150138. eCollection 2016.
PLoS One. 2016.
PMID: 26930657
Free PMC article.
Item in Clipboard
Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression.
Tseng-Rogenski S, Gee J, Ignatoski KW, Kunju LP, Bucheit A, Kintner HJ, Morris D, Tallman C, Evron J, Wood CG, Grossman HB, Lee CT, Liebert M.
Tseng-Rogenski S, et al.
Am J Pathol. 2010 Mar;176(3):1462-8. doi: 10.2353/ajpath.2010.090875. Epub 2010 Jan 21.
Am J Pathol. 2010.
PMID: 20093479
Free PMC article.
Item in Clipboard
An oncolytic measles virus engineered to enter cells through the CD20 antigen.
Bucheit AD, Kumar S, Grote DM, Lin Y, von Messling V, Cattaneo RB, Fielding AK.
Bucheit AD, et al.
Mol Ther. 2003 Jan;7(1):62-72. doi: 10.1016/s1525-0016(02)00033-3.
Mol Ther. 2003.
PMID: 12573619
Free article.
Item in Clipboard
Cite
Cite